Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States
- PMID: 25837669
- PMCID: PMC4383424
- DOI: 10.1371/journal.pone.0120574
Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States
Abstract
Background: Intrahepatic (ICC) and extrahepatic cholangiocarcinomas (ECC) are tumors that arise from cholangiocytes in the bile duct, but ICCs are coded as primary liver cancers while ECCs are coded as biliary tract cancers. The etiology of these tumors is not well understood. It has been suggested that the etiology of ICC is more similar to that of another type of liver cancer, hepatocellular carcinoma (HCC), than to the etiology of ECC. If this is true, geographic incidence patterns and trends in ICC incidence should be more similar to that of HCC than ECC.
Methods: To examine this hypothesis, data from the North American Association of Central Cancer Registries Cancer in North America data file were analyzed. Incidence rates and joinpoint trends were calculated by demographic subgroup. County-level incidence rates were mapped.
Results: Overall incidence rates, racial distribution, male:female ratio, and peak ages were more similar between ICC and ECC than with HCC. During 2000-2009, average annual incidence rates of ECC increased. During 2005-2009, average annual ICC incidence rates also increased. High rates for all three cancer sites were found in the Pacific region, particularly Hawaii and Alaska. Rates of ICC and ECC were also high in the Northeast and the upper Midwest, while rates of HCC were high in the South.
Conclusions: Demographic patterns and geographical variation were more closely related between ICC and ECC than HCC, suggesting that the etiology of ICC and ECC may be similar. Increasing rates of both tumors suggest that further etiology studies are warranted.
Conflict of interest statement
Figures
Similar articles
-
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8. doi: 10.1016/j.cgh.2007.05.020. Epub 2007 Aug 6. Clin Gastroenterol Hepatol. 2007. PMID: 17689296 Free PMC article.
-
Temporal trends and patterns for early- and late-onset adult liver cancer incidence vary by race/ethnicity, subsite, and histologic type in the United States from 2000 to 2019.Cancer Causes Control. 2025 May;36(5):551-560. doi: 10.1007/s10552-024-01955-4. Epub 2025 Jan 9. Cancer Causes Control. 2025. PMID: 39786651 Free PMC article.
-
Intrahepatic cholangiocarcinoma: new insights in pathology.Semin Liver Dis. 2011 Feb;31(1):49-60. doi: 10.1055/s-0031-1272839. Epub 2011 Feb 22. Semin Liver Dis. 2011. PMID: 21344350 Review.
-
Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.Cancer. 2020 Jun 1;126(11):2666-2678. doi: 10.1002/cncr.32803. Epub 2020 Mar 4. Cancer. 2020. PMID: 32129902 Free PMC article.
-
[Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].Zentralbl Chir. 2007 Aug;132(4):300-5. doi: 10.1055/s-2007-981195. Zentralbl Chir. 2007. PMID: 17724632 Review. German.
Cited by
-
Complex Liver Resections for Intrahepatic Cholangiocarcinoma.J Clin Med. 2021 Apr 13;10(8):1672. doi: 10.3390/jcm10081672. J Clin Med. 2021. PMID: 33924732 Free PMC article.
-
Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation.Cancers (Basel). 2024 May 21;16(11):1946. doi: 10.3390/cancers16111946. Cancers (Basel). 2024. PMID: 38893067 Free PMC article. Review.
-
Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomes.Lancet Reg Health Am. 2024 Nov 25;40:100952. doi: 10.1016/j.lana.2024.100952. eCollection 2024 Dec. Lancet Reg Health Am. 2024. PMID: 39655285 Free PMC article.
-
Metabolic characteristics distinguishing intrahepatic cholangiocarcinoma: a negative pilot study of (18)F-fluorocholine PET/CT clarified by transcriptomic analysis.Am J Nucl Med Mol Imaging. 2016 Jan 28;6(1):73-83. eCollection 2016. Am J Nucl Med Mol Imaging. 2016. PMID: 27069767 Free PMC article.
-
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.Hepatology. 2019 Apr;69(4):1803-1815. doi: 10.1002/hep.30289. Epub 2019 Mar 25. Hepatology. 2019. PMID: 30251463 Free PMC article. Review.
References
-
- Fritz A PC, Jack A, Shanmugaratnam K, Sobin LH, Parkin MD, editors. International classification of diseases for oncology (ICD-O) 3rd ed. Geneva (Switzerland): World Health Organization; 2000.
-
- Chapman RW. Risk factors for biliary tract carcinogenesis. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 1999;10 Suppl 4:308–11. - PubMed
-
- Tomimatsu M, Ishiguro N, Taniai M, Okuda H, Saito A, Obata H, et al. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer. 1993;72(3):683–8. - PubMed
-
- Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. International journal of epidemiology. 1996;25(5):933–40. - PubMed
-
- Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, et al. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer. 2000;88(11):2471–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical